These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Increased plasma endothelin levels in patients with Raynaud's phenomenon. Biondi ML; Marasini B; Bassani C; Agastoni A N Engl J Med; 1991 Apr; 324(16):1139-40. PubMed ID: 2008192 [No Abstract] [Full Text] [Related]
8. Adrenoceptors on blood cells from patients with primary Raynaud's phenomenon. Jeremy JY; Gill J; Barradas MA; Mikhailidis DP Clin Sci (Lond); 1991 Sep; 81(3):447. PubMed ID: 1655348 [No Abstract] [Full Text] [Related]
9. Effect of clonazepam on Raynaud's phenomenon and fingertip ulcers in scleroderma. Colakoğlu M; Cobankara V; Akpolat T Ann Pharmacother; 2007 Sep; 41(9):1544-7. PubMed ID: 17666574 [TBL] [Abstract][Full Text] [Related]
10. Raynaud's phenomenon: pathogenesis and management. Bakst R; Merola JF; Franks AG; Sanchez M J Am Acad Dermatol; 2008 Oct; 59(4):633-53. PubMed ID: 18656283 [TBL] [Abstract][Full Text] [Related]
11. Current drug therapy for scleroderma and secondary Raynaud's phenomenon: evidence-based review. Henness S; Wigley FM Curr Opin Rheumatol; 2007 Nov; 19(6):611-8. PubMed ID: 17917543 [TBL] [Abstract][Full Text] [Related]
12. Anorexia nervosa and Raynaud's phenomenon: a case report. Yucel B; Uzum AK; Ozbey N; Kamali S; Yager J Int J Eat Disord; 2007 Dec; 40(8):762-5. PubMed ID: 17607716 [TBL] [Abstract][Full Text] [Related]